Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of Multiple Doses of JS002 in Patients With Hyperlipidemia.. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating multiple doses of JS002 for hyperlipidemia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• JS002

Snippet

Sponsor: Shanghai Junshi Bioscience Co., Ltd. | Conditions: Hyperlipemia | Phase 1, Phase 2 | Status: COMPLETED